Olanzapine and Zoledronic acid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Olanzapine (olanzapine) and Zoledronic acid (zoledronic acid). Common drug interactions include pulmonary embolism among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Olanzapine and Zoledronic acid. It is created by eHealthMe based on reports of 102 people who take the same drugs from the FDA, and is updated regularly.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.
What is Zoledronic acid?
Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.
102 people who take Olanzapine and Zoledronic acid together, and have interactions are studied.
What are the common drug interactions of Olanzapine and Zoledronic acid, by gender? *
What are the common drug interactions of Olanzapine and Zoledronic acid, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Olanzapine and Zoledronic acid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Olanzapine (69,242 reports)
- Zoledronic acid (28,485 reports)
Browse all drug interactions of Olanzapine and Zoledronic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zoledronic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olanzapine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoledronic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine and zoledronic acid (the active ingredients of Olanzapine and Zoledronic acid, respectively), and Olanzapine and Zoledronic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hiv Infection and Pleural Effusion - 2 seconds ago
- Drug interactions of Mycophenolate Mofetil and Nortriptyline Hydrochloride - 2 seconds ago
- Could Mobic cause Hepatic Encephalopathy? - 21 seconds ago
- Drug interactions of Asacol Hd and Fish Oil - 29 seconds ago
- Could Cefazolin cause Muscle Function Loss? - 35 seconds ago
- Could Cannabis Sativa cause Aggression Aggravated? - 36 seconds ago
- Could Klor-Con cause Oesophageal Disorder? - 37 seconds ago
- Drug interactions of Q10 and Cambia - 45 seconds ago
- Could Tarceva cause Head Injury? - 58 seconds ago
- Could Amitriptyline Hydrochloride cause Cardiogenic Shock? - a minute ago